Susceptibility patterns in Pseudomonas aeruginosa causing nosocomial infections

Journal of Chemotherapy

Volumn 16, Issue 3, 2004, Pages 264-268

  Astal, Z ^a,b  

^a Khan Younis Hospital Laboratory   (Israel)

^b Khan Younis Hospital Laboratory   (Israel)

Author keywords

Antimicrobial resistance; Nosocomial infection; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; CEFALEXIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; DOXYCYCLINE; GENTAMICIN; MEROPENEM; PIPERACILLIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DISEASE PREDISPOSITION; GRAM NEGATIVE INFECTION; HOSPITAL DEPARTMENT; HOSPITAL INFECTION; INTENSIVE CARE UNIT; NONHUMAN; PALESTINE; PSEUDOMONAS AERUGINOSA; SURGICAL PATIENT;

EID: 3843052541     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2004.16.3.264     Document Type: Article

References (19)

1. Lee S, Fung C, Liu PY, et al. Nosocomial infections with ceftazidime-resistant Pseudomonas aeruginosa: risk factors and outcome. Infect Control Hosp Epidemiol 1999; 20: 205-207.
2. Lepper PM, Grusa E, Reichl H, Högel J, Trautmann M. Consumption of imipenem correlates with β-lactam resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2002; 46(9): 2920-2925.
3. Chatzinikolaou, I, Abi-Said D, Bodey GP, Rolston KV, Tarrand JJ, Samonis G. Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: retrospective analysis of 245 episodes. Arch Intern Med 2000; 160: 501-509.
4. De Tese R. Nosocomial infection caused by multi-resistant Pseudomonas aeruginosa: epidemiological analysis at HC-FMUSP. Revista da Sociedade Brasileira de Medicina Tropical 1998; 31 (5): 503-504.
5. Van Eldere J. Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections. J Antimicrob Chemother 2003; 51: 347-352.
6. Jones RN, Kirby JT, Beach ML, Biedenbach DJ, Pfaller MA. Geographic variations in activity of broad-spectrum β-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000). Diag Microbiol Infect Dis 2002; 43(3): 239-243.
7. Jones RN, Varnam, DJ. Antimicrobial activity of broad-spectrum agents tested against gram-negative bacilli resistant to ceftazidime: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). Diag Microbiol Infect Dis 2002; 44(4): 379-382.
8. Rotimi VO, Al-Sweih NA, Feteih J. The prevalence and antibiotic susceptibility pattern of Gram-negative bacterial isolates in two ICUs in Saudi Arabia and Kuwait. Diag Microbiol Infect Dis 1998; 30(1): 53-59.
9. Wood AJJ. Antimicrobial-drug resistance. N Engl J Med 1996; 335: 1445-1453.
10. th Ed. Butterworth-Heinemann Ltd. Britain. 1995; 284-286.
11. Bauer AM, Kirby WMM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standard simple disk method. Am J Clin Pathol 1966; 45: 493-496.
12. National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial susceptibility testing. Eleventh Informational Supplement. Document M100-S11, 2001; Vol. 21. No. 1. NCCLS, Wayne, PA.
13. Hsueh PR, Chen ML, Sun CC, et al. Antimicrobial drug resistance in pathogens causing nosocomial infections at a university hospital in Taiwan, 1981-1999. Emerg Infect Dis 2002; 8(1): 63-68.
14. Aka J, Dosso M, Michel G. Antibiotic resistance of Pseudomonas aeruginosa: a fact and a problem at the University Hospital Center of Cocody (Abidjan). Med Trop 1987; 47(1): 53-59.
15. Gales AC, Sader HS, Jones RN. Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia in Latin America: frequency of occurrence and antimicrobial susceptibility profile: results from the SENTRY Antimicrobial Surveillance Program (1997-2000). Diag Microbiol Infect Dis 2002; 44(3): 301-311.
16. rd Ed. Mass Publishing Co. 1997; 713-714.
17. Jones RN, Pfaller MA, Marshall SA, Hollis RJ, Wilke WW. Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric gram-negative bacilli: occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes. Diag Microbiol Infect Dis 1997; 29(3): 187-192.
18. Laverdière M, Gallimore B, Restieri C, Poonia K, Chow AW. In vitro synergism of ceftriaxone combined with amino-glycosides against Pseudomonas aeruginosa. Diag Microbiol Infect Dis 1994; 19(1): 39-46.
19. Nitzan Y, Sharon R, Maayan M, Steuerman C. Pseudomonas aeruginosa isolates from different medical institutions. Isr J Med Sci 1985; 2(10): 798-803.